Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(2)
MIXED(1)
AN0025
1 trial
phase_1
adlai-nortye-biopharma-co-ltd
AN2025
1 trial
phase_1
adlai-nortye-biopharma-co-ltd
Atezolizumab 1200 mg in 20 ML Injection
1 trial
phase_1
adlai-nortye-biopharma-co-ltd
3 unique interventions2 categories

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT04975958Phase 1Completed
Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors
Locally Advanced Solid Tumor
StudydirectorStart date: 2021-09-07

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Locally Advanced Solid Tumor1

Affiliations

Adlai Nortye US Inc

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Kim Taubman

St Vincent Hospital Melbourne

Moderately Similar
1 trials

Shared therapeutic areas:

Locally Advanced Solid Tumor
Similarity Score30%

Morteza Aghmesheh

Southern Medical Day Care Centre

Moderately Similar
2 trials

Shared therapeutic areas:

Locally Advanced Solid Tumor
Similarity Score30%

Christopher Nevala-Plagemann, MD

Huntsman Cancer Institute

Moderately Similar
1 trials

Shared therapeutic areas:

Locally Advanced Solid Tumor
Similarity Score30%

Karim Malek, MD

Ikena Oncology

Moderately Similar
2 trials

Shared therapeutic areas:

Locally Advanced Solid Tumor
Similarity Score30%

Elisabeth G.E. de Vries, MD, PhD

University Medical Center Groningen

Moderately Similar
3 trials

Shared therapeutic areas:

Locally Advanced Solid Tumor
Similarity Score30%

Maxim Pimkin, MD, PhD

Tango Therapeutics, Inc.

Moderately Similar
1 trials

Shared therapeutic areas:

Locally Advanced Solid Tumor
Similarity Score30%

Apostolia Tsimberidou, MD, PhD

M.D. Anderson Cancer Center

Moderately Similar
6 trials

Shared therapeutic areas:

Locally Advanced Solid Tumor
Similarity Score30%

Armelle DUFRESNE

Centre Leon Berard

Moderately Similar
1 trials

Shared therapeutic areas:

Locally Advanced Solid Tumor
Similarity Score30%

Michael Kurman, MD

Acepodia Biotech, Inc.

Moderately Similar
1 trials

Shared therapeutic areas:

Locally Advanced Solid Tumor
Similarity Score30%

Benjamin Oshrine

Parabilis Medicines, Inc.

Moderately Similar
1 trials

Shared therapeutic areas:

Locally Advanced Solid Tumor
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04975958Phase 1StudyDirector

Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors

Locally Advanced Solid Tumor
Completed

All 1 trials loaded